201 related articles for article (PubMed ID: 8080851)
1. New approaches in brain tumor therapy using gene transfer and antisense oligonucleotides.
Yung WK
Curr Opin Oncol; 1994 May; 6(3):235-9. PubMed ID: 8080851
[TBL] [Abstract][Full Text] [Related]
2. New approaches to molecular therapy of brain tumors.
Yung WK
Curr Opin Neurol; 1994 Dec; 7(6):501-5. PubMed ID: 7866580
[TBL] [Abstract][Full Text] [Related]
3. Cellular and molecular neurosurgery: pathways from concept to reality--part I: target disorders and concept approaches to gene therapy of the central nervous system.
Zlokovic BV; Apuzzo ML
Neurosurgery; 1997 Apr; 40(4):789-803; discussion 803-4. PubMed ID: 9092853
[TBL] [Abstract][Full Text] [Related]
4. [Gene therapy: new developments].
Mohr L; Geissler M
Praxis (Bern 1994); 2002 Dec; 91(51-52):2227-35. PubMed ID: 12564039
[TBL] [Abstract][Full Text] [Related]
5. Gene therapy for the treatment of brain tumors using intra-tumoral transduction with the thymidine kinase gene and intravenous ganciclovir.
Oldfield EH; Ram Z; Culver KW; Blaese RM; DeVroom HL; Anderson WF
Hum Gene Ther; 1993 Feb; 4(1):39-69. PubMed ID: 8384892
[TBL] [Abstract][Full Text] [Related]
6. Antisense inhibition and adeno-associated viral vector delivery for reducing hypertension.
Phillips MI
Hypertension; 1997 Jan; 29(1 Pt 2):177-87. PubMed ID: 9039099
[TBL] [Abstract][Full Text] [Related]
7. Downregulation of cyclin G1 expression by retrovirus-mediated antisense gene transfer inhibits vascular smooth muscle cell proliferation and neointima formation.
Zhu NL; Wu L; Liu PX; Gordon EM; Anderson WF; Starnes VA; Hall FL
Circulation; 1997 Jul; 96(2):628-35. PubMed ID: 9244236
[TBL] [Abstract][Full Text] [Related]
8. Gene and other biological therapies for vascular diseases.
Stephan D; Nabel EG
Fundam Clin Pharmacol; 1997; 11(2):97-110. PubMed ID: 9107554
[TBL] [Abstract][Full Text] [Related]
9. Therapy of malignant brain tumors by intratumoral implantation of retroviral vector-producing cells.
Ram Z; Culver KW; Oshiro EM; Viola JJ; DeVroom HL; Otto E; Long Z; Chiang Y; McGarrity GJ; Muul LM; Katz D; Blaese RM; Oldfield EH
Nat Med; 1997 Dec; 3(12):1354-61. PubMed ID: 9396605
[TBL] [Abstract][Full Text] [Related]
10. Antisense oligonucleotide therapy in the management of bladder cancer.
So A; Rocchi P; Gleave M
Curr Opin Urol; 2005 Sep; 15(5):320-7. PubMed ID: 16093856
[TBL] [Abstract][Full Text] [Related]
11. Gene therapy and vascular disease.
Kibbe M; Billiar T; Tzeng E
Adv Pharmacol; 1999; 46():85-150. PubMed ID: 10332502
[No Abstract] [Full Text] [Related]
12. Short-term neuropathological aspects of in vivo suicide gene transfer to the F98 rat glioblastoma using liposomal and viral vectors.
von Eckardstein KL; Patt S; Zhu J; Zhang L; Cervós-Navarro J; Reszka R
Histol Histopathol; 2001 Jul; 16(3):735-44. PubMed ID: 11510963
[TBL] [Abstract][Full Text] [Related]
13. Antisense oligonucleotides as therapeutic agents.
Alama A; Barbieri F; Cagnoli M; Schettini G
Pharmacol Res; 1997 Sep; 36(3):171-8. PubMed ID: 9367660
[TBL] [Abstract][Full Text] [Related]
14. Antisense Oligonucleotide-Based Therapy for Neuromuscular Disease.
Sardone V; Zhou H; Muntoni F; Ferlini A; Falzarano MS
Molecules; 2017 Apr; 22(4):. PubMed ID: 28379182
[TBL] [Abstract][Full Text] [Related]
15. In situ retroviral-mediated gene transfer for the treatment of brain tumors in rats.
Ram Z; Culver KW; Walbridge S; Blaese RM; Oldfield EH
Cancer Res; 1993 Jan; 53(1):83-8. PubMed ID: 8380127
[TBL] [Abstract][Full Text] [Related]
16. Gene therapy for malignant glioma: current clinical status.
Pulkkanen KJ; Yla-Herttuala S
Mol Ther; 2005 Oct; 12(4):585-98. PubMed ID: 16095972
[TBL] [Abstract][Full Text] [Related]
17. Gene therapy for brain tumors.
Bansal K; Engelhard HH
Curr Oncol Rep; 2000 Sep; 2(5):463-72. PubMed ID: 11122879
[TBL] [Abstract][Full Text] [Related]
18. Molecular therapies for malignant glioma.
Hutterer M; Gunsilius E; Stockhammer G
Wien Med Wochenschr; 2006 Jun; 156(11-12):351-63. PubMed ID: 16944367
[TBL] [Abstract][Full Text] [Related]
19. Beta-galactosidase gene transfer to human malignant glioma in vivo using replication-deficient retroviruses and adenoviruses.
Puumalainen AM; Vapalahti M; Agrawal RS; Kossila M; Laukkanen J; Lehtolainen P; Viita H; Paljärvi L; Vanninen R; Ylä-Herttuala S
Hum Gene Ther; 1998 Aug; 9(12):1769-74. PubMed ID: 9721087
[TBL] [Abstract][Full Text] [Related]
20. Use of antisense vectors and oligodeoxynucleotides in neuro-oncology.
Engelhard HH; Egli M; Rozental JM
Pediatr Neurosurg; 1998 Jun; 28(6):279-85. PubMed ID: 9782204
[No Abstract] [Full Text] [Related]
[Next] [New Search]
